🔗 Share this article

This year's Nobel Prize in medical science has been granted for transformative discoveries that illuminate how the body's defense network attacks dangerous infections while protecting the body's own cells.

A trio of esteemed researchers—Japan's Shimon Sakaguchi and American scientists Dr. Brunkow and Dr. Ramsdell—share this accolade.

The work identified specialized "security guards" within the immune system that eliminate rogue defense cells capable of attacking the organism.

These discoveries are now enabling new therapies for immune disorders and malignancies.

These laureates will divide a monetary award worth 11m Swedish kronor.

Crucial Discoveries

"Their work has been essential for comprehending how the body's defenses operates and the reason we don't all develop severe autoimmune diseases," commented the head of the Nobel Committee.

This trio's studies address a fundamental question: How does the immune system protect us from countless invaders while keeping our own tissues unharmed?

The immune system employs white blood cells that search for indicators of infection, including viruses and germs it has never encountered.

These cells utilize detectors—called receptors—that are produced randomly in a vast number of combinations.

That provides the immune system the capacity to fight a broad range of invaders, but the randomness of the process inevitably produces immune cells that may attack the host.

Protectors of the Immune System

Researchers previously knew that a portion of these problematic white blood cells were eliminated in the immune organ—the site where immune cells develop.

This year's Nobel Prize honors the discovery of T-reg cells—known as the immune system's "peacekeepers"—which patrol the system to disarm any immune cells that assault the body's own tissues.

We know that this mechanism fails in autoimmune diseases such as juvenile diabetes, multiple sclerosis, and rheumatoid arthritis.

The prize committee added, "The findings have established a new field of research and accelerated the creation of innovative treatments, for instance for cancer and immune disorders."

In cancer, regulatory T-cells prevent the body from attacking the tumor, so research are aimed at reducing their quantity.

In self-attack disorders, experiments are exploring increasing regulatory T-cells so the organism is no longer being harmed. A comparable method could also be effective in minimizing the chances of organ transplant rejection.

Pioneering Studies

Professor Shimon Sakaguchi, of Osaka University, performed experiments on mice that had their immune gland extracted, leading to self-attack conditions.

He showed that injecting defense cells from other animals could prevent the illness—suggesting there was a system for preventing defenders from harming the body.

Mary Brunkow, affiliated with the a research center in Seattle, and Dr. Ramsdell, currently at a biotech firm in a California city, were investigating an inherited autoimmune disease in mice and humans that led to the discovery of a gene vital for how T-regs operate.

"The groundbreaking research has revealed how the body's defenses is controlled by T-reg cells, stopping it from mistakenly attacking the body's own tissues," said a leading biological science specialist.

"This research is a remarkable example of how fundamental physiological research can have broad consequences for human health."